TABLE 3.
Antimicrobial resistance patterns among V. vulnificus strains isolated during the oyster relaying process
Antibiotic | % with profilea: |
||
---|---|---|---|
S | I | R | |
Amikacinb | 88 | 12 | 0 |
Amoxicillin-clavulanic acid | 66 | 9 | 26 |
Ampicillin | 72 | 2 | 26 |
Ampicillin-sulbactam | 93 | 3 | 3 |
Cefepime | 93 | 5 | 2 |
Cefotaximeb | 91 | 2 | 7 |
Cefoxitin | 36 | 47 | 17 |
Ceftazidimeb | 72 | 16 | 12 |
Ceftriaxoneb | 78 | 10 | 12 |
Cephalothin | 31 | 2 | 67 |
Chloramphenicol | 86 | 12 | 2 |
Ciprofloxacinb | 100 | 0 | 0 |
Doxycyclineb | 71 | 9 | 21 |
Imipenem | 76 | 9 | 16 |
Levofloxacinb | 100 | 0 | 0 |
Meropenem | 95 | 5 | 0 |
Piperacillin | 100 | 0 | 0 |
Piperacillin-tazobactam | 100 | 0 | 0 |
Tetracyclineb | 64 | 7 | 29 |
Trimethoprim-sulfamethoxazoleb | 98 | 0 | 2 |
S, susceptible; I, intermediate; R, resistant.
CDC-recommended antibiotic for Vibrio infections.